Anti-Interleukin-6 Therapy for Crohns Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
295-305
Author(s):
H. Ito
Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
307-321
Author(s):
Koji Sawada, Tetsuichiro Muto, Takashi Shimoyama, Masamichi Satomi, Toshio Sawada, Hirokazu Nagawa, Nobuo Hiwatashi, Hitoshi Asakura and Toshifumi Hibi
Role of Type I Cytokines in Host Defense Against Mycobacterium avium Infection
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
61-65
Author(s):
Lia Danelishvilli and Luiz E. Bermudez
Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
83-94
Author(s):
Ciriaco A. Piccirillo and Gerald J. Prud'homme
“Multi-component Reactions : Emerging Chemistry in Drug Discovery” ‘From Xylocain to Crixivan’
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
51-80
Author(s):
Christopher Hulme and Vijay Gore
Subject Index To Volume 9
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
87-96
Author(s):
Bentham Science Publishers
Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
201-220
Author(s):
M. T. Wilson and L. Van. Kaer
Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
245-256
Author(s):
Orhan Aktas and Frauke Zipp
Gene Therapy and Biologic Therapy with Interleukin?4
Journal:
Current Gene Therapy
Volume:
2
Page:
437-450
Author(s):
Hideho Okada and Naruo Kuwashima
Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
167-175
Author(s):
P- J. Jakobsson, D. Engblom, A. Ericsson-Dahlstrand and A. Blomqvist